Anti-Obesity Drugs Market

Global Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2029

Report Id: KBV-14786 Publication Date: April-2023 Number of Pages: 220
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Anti-Obesity Drugs Market, by Drug Type
1.4.2 Global Anti-Obesity Drugs Market, by Mechanism of Action
1.4.3 Global Anti-Obesity Drugs Market, by Route Of Administration
1.4.4 Global Anti-Obesity Drugs Market, by Distribution Channel
1.4.5 Global Anti-Obesity Drugs Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Anti-Obesity Drugs Market by Drug Type
3.1 Global Prescription Drugs Market by Region
3.2 Global Over The Counter Drugs Market by Region

Chapter 4. Global Anti-Obesity Drugs Market by Mechanism of Action
4.1 Global Centrally Acting Market by Region
4.2 Global Peripherally Acting Market by Region

Chapter 5. Global Anti-Obesity Drugs Market by Route Of Administration
5.1 Global Oral Route Market by Region
5.2 Global Subcutaneous Route Market by Region

Chapter 6. Global Anti-Obesity Drugs Market by Distribution Channel
6.1 Global Hospital Pharmacies Market by Region
6.2 Global Retail Pharmacies Market by Region
6.3 Global Online Pharmacies Market by Region

Chapter 7. Global Anti-Obesity Drugs Market by Region
7.1 North America Anti-Obesity Drugs Market
7.1.1 North America Anti-Obesity Drugs Market by Drug Type
7.1.1.1 North America Prescription Drugs Market by Country
7.1.1.2 North America Over The Counter Drugs Market by Country
7.1.2 North America Anti-Obesity Drugs Market by Mechanism of Action
7.1.2.1 North America Centrally Acting Market by Country
7.1.2.2 North America Peripherally Acting Market by Country
7.1.3 North America Anti-Obesity Drugs Market by Route Of Administration
7.1.3.1 North America Oral Route Market by Country
7.1.3.2 North America Subcutaneous Route Market by Country
7.1.4 North America Anti-Obesity Drugs Market by Distribution Channel
7.1.4.1 North America Hospital Pharmacies Market by Country
7.1.4.2 North America Retail Pharmacies Market by Country
7.1.4.3 North America Online Pharmacies Market by Country
7.1.5 North America Anti-Obesity Drugs Market by Country
7.1.5.1 US Anti-Obesity Drugs Market
7.1.5.1.1 US Anti-Obesity Drugs Market by Drug Type
7.1.5.1.2 US Anti-Obesity Drugs Market by Mechanism of Action
7.1.5.1.3 US Anti-Obesity Drugs Market by Route Of Administration
7.1.5.1.4 US Anti-Obesity Drugs Market by Distribution Channel
7.1.5.2 Canada Anti-Obesity Drugs Market
7.1.5.2.1 Canada Anti-Obesity Drugs Market by Drug Type
7.1.5.2.2 Canada Anti-Obesity Drugs Market by Mechanism of Action
7.1.5.2.3 Canada Anti-Obesity Drugs Market by Route Of Administration
7.1.5.2.4 Canada Anti-Obesity Drugs Market by Distribution Channel
7.1.5.3 Mexico Anti-Obesity Drugs Market
7.1.5.3.1 Mexico Anti-Obesity Drugs Market by Drug Type
7.1.5.3.2 Mexico Anti-Obesity Drugs Market by Mechanism of Action
7.1.5.3.3 Mexico Anti-Obesity Drugs Market by Route Of Administration
7.1.5.3.4 Mexico Anti-Obesity Drugs Market by Distribution Channel
7.1.5.4 Rest of North America Anti-Obesity Drugs Market
7.1.5.4.1 Rest of North America Anti-Obesity Drugs Market by Drug Type
7.1.5.4.2 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action
7.1.5.4.3 Rest of North America Anti-Obesity Drugs Market by Route Of Administration
7.1.5.4.4 Rest of North America Anti-Obesity Drugs Market by Distribution Channel
7.2 Europe Anti-Obesity Drugs Market
7.2.1 Europe Anti-Obesity Drugs Market by Drug Type
7.2.1.1 Europe Prescription Drugs Market by Country
7.2.1.2 Europe Over The Counter Drugs Market by Country
7.2.2 Europe Anti-Obesity Drugs Market by Mechanism of Action
7.2.2.1 Europe Centrally Acting Market by Country
7.2.2.2 Europe Peripherally Acting Market by Country
7.2.3 Europe Anti-Obesity Drugs Market by Route Of Administration
7.2.3.1 Europe Oral Route Market by Country
7.2.3.2 Europe Subcutaneous Route Market by Country
7.2.4 Europe Anti-Obesity Drugs Market by Distribution Channel
7.2.4.1 Europe Hospital Pharmacies Market by Country
7.2.4.2 Europe Retail Pharmacies Market by Country
7.2.4.3 Europe Online Pharmacies Market by Country
7.2.5 Europe Anti-Obesity Drugs Market by Country
7.2.5.1 Germany Anti-Obesity Drugs Market
7.2.5.1.1 Germany Anti-Obesity Drugs Market by Drug Type
7.2.5.1.2 Germany Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.1.3 Germany Anti-Obesity Drugs Market by Route Of Administration
7.2.5.1.4 Germany Anti-Obesity Drugs Market by Distribution Channel
7.2.5.2 UK Anti-Obesity Drugs Market
7.2.5.2.1 UK Anti-Obesity Drugs Market by Drug Type
7.2.5.2.2 UK Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.2.3 UK Anti-Obesity Drugs Market by Route Of Administration
7.2.5.2.4 UK Anti-Obesity Drugs Market by Distribution Channel
7.2.5.3 France Anti-Obesity Drugs Market
7.2.5.3.1 France Anti-Obesity Drugs Market by Drug Type
7.2.5.3.2 France Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.3.3 France Anti-Obesity Drugs Market by Route Of Administration
7.2.5.3.4 France Anti-Obesity Drugs Market by Distribution Channel
7.2.5.4 Russia Anti-Obesity Drugs Market
7.2.5.4.1 Russia Anti-Obesity Drugs Market by Drug Type
7.2.5.4.2 Russia Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.4.3 Russia Anti-Obesity Drugs Market by Route Of Administration
7.2.5.4.4 Russia Anti-Obesity Drugs Market by Distribution Channel
7.2.5.5 Spain Anti-Obesity Drugs Market
7.2.5.5.1 Spain Anti-Obesity Drugs Market by Drug Type
7.2.5.5.2 Spain Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.5.3 Spain Anti-Obesity Drugs Market by Route Of Administration
7.2.5.5.4 Spain Anti-Obesity Drugs Market by Distribution Channel
7.2.5.6 Italy Anti-Obesity Drugs Market
7.2.5.6.1 Italy Anti-Obesity Drugs Market by Drug Type
7.2.5.6.2 Italy Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.6.3 Italy Anti-Obesity Drugs Market by Route Of Administration
7.2.5.6.4 Italy Anti-Obesity Drugs Market by Distribution Channel
7.2.5.7 Rest of Europe Anti-Obesity Drugs Market
7.2.5.7.1 Rest of Europe Anti-Obesity Drugs Market by Drug Type
7.2.5.7.2 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.7.3 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration
7.2.5.7.4 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel
7.3 Asia Pacific Anti-Obesity Drugs Market
7.3.1 Asia Pacific Anti-Obesity Drugs Market by Drug Type
7.3.1.1 Asia Pacific Prescription Drugs Market by Country
7.3.1.2 Asia Pacific Over The Counter Drugs Market by Country
7.3.2 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action
7.3.2.1 Asia Pacific Centrally Acting Market by Country
7.3.2.2 Asia Pacific Peripherally Acting Market by Country
7.3.3 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration
7.3.3.1 Asia Pacific Oral Route Market by Country
7.3.3.2 Asia Pacific Subcutaneous Route Market by Country
7.3.4 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel
7.3.4.1 Asia Pacific Hospital Pharmacies Market by Country
7.3.4.2 Asia Pacific Retail Pharmacies Market by Country
7.3.4.3 Asia Pacific Online Pharmacies Market by Country
7.3.5 Asia Pacific Anti-Obesity Drugs Market by Country
7.3.5.1 China Anti-Obesity Drugs Market
7.3.5.1.1 China Anti-Obesity Drugs Market by Drug Type
7.3.5.1.2 China Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.1.3 China Anti-Obesity Drugs Market by Route Of Administration
7.3.5.1.4 China Anti-Obesity Drugs Market by Distribution Channel
7.3.5.2 Japan Anti-Obesity Drugs Market
7.3.5.2.1 Japan Anti-Obesity Drugs Market by Drug Type
7.3.5.2.2 Japan Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.2.3 Japan Anti-Obesity Drugs Market by Route Of Administration
7.3.5.2.4 Japan Anti-Obesity Drugs Market by Distribution Channel
7.3.5.3 India Anti-Obesity Drugs Market
7.3.5.3.1 India Anti-Obesity Drugs Market by Drug Type
7.3.5.3.2 India Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.3.3 India Anti-Obesity Drugs Market by Route Of Administration
7.3.5.3.4 India Anti-Obesity Drugs Market by Distribution Channel
7.3.5.4 South Korea Anti-Obesity Drugs Market
7.3.5.4.1 South Korea Anti-Obesity Drugs Market by Drug Type
7.3.5.4.2 South Korea Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.4.3 South Korea Anti-Obesity Drugs Market by Route Of Administration
7.3.5.4.4 South Korea Anti-Obesity Drugs Market by Distribution Channel
7.3.5.5 Singapore Anti-Obesity Drugs Market
7.3.5.5.1 Singapore Anti-Obesity Drugs Market by Drug Type
7.3.5.5.2 Singapore Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.5.3 Singapore Anti-Obesity Drugs Market by Route Of Administration
7.3.5.5.4 Singapore Anti-Obesity Drugs Market by Distribution Channel
7.3.5.6 Malaysia Anti-Obesity Drugs Market
7.3.5.6.1 Malaysia Anti-Obesity Drugs Market by Drug Type
7.3.5.6.2 Malaysia Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.6.3 Malaysia Anti-Obesity Drugs Market by Route Of Administration
7.3.5.6.4 Malaysia Anti-Obesity Drugs Market by Distribution Channel
7.3.5.7 Rest of Asia Pacific Anti-Obesity Drugs Market
7.3.5.7.1 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type
7.3.5.7.2 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.7.3 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration
7.3.5.7.4 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel
7.4 LAMEA Anti-Obesity Drugs Market
7.4.1 LAMEA Anti-Obesity Drugs Market by Drug Type
7.4.1.1 LAMEA Prescription Drugs Market by Country
7.4.1.2 LAMEA Over The Counter Drugs Market by Country
7.4.2 LAMEA Anti-Obesity Drugs Market by Mechanism of Action
7.4.2.1 LAMEA Centrally Acting Market by Country
7.4.2.2 LAMEA Peripherally Acting Market by Country
7.4.3 LAMEA Anti-Obesity Drugs Market by Route Of Administration
7.4.3.1 LAMEA Oral Route Market by Country
7.4.3.2 LAMEA Subcutaneous Route Market by Country
7.4.4 LAMEA Anti-Obesity Drugs Market by Distribution Channel
7.4.4.1 LAMEA Hospital Pharmacies Market by Country
7.4.4.2 LAMEA Retail Pharmacies Market by Country
7.4.4.3 LAMEA Online Pharmacies Market by Country
7.4.5 LAMEA Anti-Obesity Drugs Market by Country
7.4.5.1 Brazil Anti-Obesity Drugs Market
7.4.5.1.1 Brazil Anti-Obesity Drugs Market by Drug Type
7.4.5.1.2 Brazil Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.1.3 Brazil Anti-Obesity Drugs Market by Route Of Administration
7.4.5.1.4 Brazil Anti-Obesity Drugs Market by Distribution Channel
7.4.5.2 Argentina Anti-Obesity Drugs Market
7.4.5.2.1 Argentina Anti-Obesity Drugs Market by Drug Type
7.4.5.2.2 Argentina Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.2.3 Argentina Anti-Obesity Drugs Market by Route Of Administration
7.4.5.2.4 Argentina Anti-Obesity Drugs Market by Distribution Channel
7.4.5.3 UAE Anti-Obesity Drugs Market
7.4.5.3.1 UAE Anti-Obesity Drugs Market by Drug Type
7.4.5.3.2 UAE Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.3.3 UAE Anti-Obesity Drugs Market by Route Of Administration
7.4.5.3.4 UAE Anti-Obesity Drugs Market by Distribution Channel
7.4.5.4 Saudi Arabia Anti-Obesity Drugs Market
7.4.5.4.1 Saudi Arabia Anti-Obesity Drugs Market by Drug Type
7.4.5.4.2 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.4.3 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration
7.4.5.4.4 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel
7.4.5.5 South Africa Anti-Obesity Drugs Market
7.4.5.5.1 South Africa Anti-Obesity Drugs Market by Drug Type
7.4.5.5.2 South Africa Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.5.3 South Africa Anti-Obesity Drugs Market by Route Of Administration
7.4.5.5.4 South Africa Anti-Obesity Drugs Market by Distribution Channel
7.4.5.6 Nigeria Anti-Obesity Drugs Market
7.4.5.6.1 Nigeria Anti-Obesity Drugs Market by Drug Type
7.4.5.6.2 Nigeria Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.6.3 Nigeria Anti-Obesity Drugs Market by Route Of Administration
7.4.5.6.4 Nigeria Anti-Obesity Drugs Market by Distribution Channel
7.4.5.7 Rest of LAMEA Anti-Obesity Drugs Market
7.4.5.7.1 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type
7.4.5.7.2 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.7.3 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration
7.4.5.7.4 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel

Chapter 8. Company Profiles
8.1 Pfizer, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expense
8.2 Boehringer Ingelheim International Gmbh
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 GlaxoSmithKline PLC (GSK)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Novo Nordisk A/S
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental & Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 Rhythm Pharmaceuticals, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.6 Gelesis Holdings Inc (PureTech Health)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.4.2 Approvals and Trials:
8.7 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Acquisition and Mergers:
8.8 Vivus LLC
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Approvals and Trials:
8.9 CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
8.9.1 Company Overview
8.10. KVK Tech, Inc.
8.10.1 Company Overview
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo